Carcell's "Powertrain" platform accelerates cell and gene therapy development from discovery to clinical proof of concept. We have two delivery platform technologies that uses red blood cells and lipid nanoparticles for effective and safe drug delivery
Carcell's leadership team has rich experience in cell and gene therapy development, with track records in early-stage R&D, CMC and manufacturing, regulatory filing and clinical trials.
Carcell is hiring talented and driven individuals to join our expanding team. We have R&D teams, central function teams, and manufacturing infrastructure based in Shanghai & Singapore.